In prostate cancer cells, melatonin inhibits the phosphorylation of both Akt and its target GSK-3β, indicating that the pineal hormone inhibits the migration and invasion of PCa cells, at least in part, by suppressing the AKT/GSK-3β-mediated EMT [157]. The gene discussed is AKT1; the disease is prostate carcinoma.